Bankrupt DNA testing company 23andMe to be bought by Regeneron
[ad_1] Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million USD through a bankruptcy auction, the companies said on Monday. Regeneron said it will comply with 23andMe’s privacy policies and applicable laws with respect to the use of customer data and…







